Paige.AI
About Paige.AI
Paige.AI is a leading healthcare artificial intelligence (AI) company dedicated to revolutionizing cancer diagnostics and treatment through advanced computational pathology. The company leverages extensive datasets of digitized pathology slides, clinical reports, and genomic data to develop AI-powered solutions that enhance the precision and efficiency of cancer detection and characterization. For physicians, Paige’s technology acts as a tireless partner, assisting in the identification of subtle markers of disease, reducing the likelihood of false negatives, and streamlining diagnostic workflows to improve turnaround times for patients.
Paige’s portfolio includes AI-assisted diagnostic applications designed to support decision-making across various cancer types, such as Paige Prostate, Paige Breast Suite, Paige GI Suite, and PanCancer Detect. These tools not only aid in detecting and subtyping cancer but also in revealing molecular biomarkers directly from tissue samples, which traditionally require more time-consuming genetic testing. The company’s innovative approach, including its foundation models like Virchow and the co-pilot platform Paige Alba™, aims to integrate AI seamlessly into existing digital pathology workflows, empowering pathologists and oncologists with real-time insights for more informed and personalized treatment decisions.
Paige’s commitment to advancing precision medicine is underscored by its development of AI applications that can identify both common and rare cancer variants across different anatomic sites, and its focus on multimodal AI models that combine imaging, genomics, pathology, and language data. By automating routine tasks and providing an added layer of diagnostic confidence, Paige’s solutions enable healthcare professionals to focus on complex cases and deliver high-quality diagnoses with remarkable sensitivity and specificity.
Focus Areas
Business Intelligence
| Key Investors | Goldman Sachs, Casdin Capital, Johnson & Johnson Innovation – JJDC, KKR, Breyer Capital, Catalio Capital Management, Healthcare Venture Partners, AI Venture Labs |
| Partnerships | Microsoft (Azure, AI model development), Quest Diagnostics, Philips, Lumea, Breast International Group (BIG), Oncoclínicas, Indica Labs |
| Acquisitions | Acquired by Tempus AI on August 22, 2025, for $81.25M |
| Technology | AI-first digital pathology platform, deep learning algorithms, computational pathology, foundation models (Virchow, PRISM), cloud-based (Microsoft Azure, AWS Cloud), integrates with LIS and image management systems, multimodal AI models (Large Vision Models with Large Language Models) |
| FDA Clearances | 2 (Paige Prostate Detect, FullFocus) cleared products (estimated) |
What Physicians Need to Know
For physicians, Paige.AI's solutions offer significant advantages by enhancing diagnostic accuracy and confidence, streamlining workflows, and providing comprehensive cancer insights. The AI can act as a 'second read' tool, prioritize cases, and reduce the need for additional staining or external consultations, ultimately decreasing turnaround times. The ability to detect biomarkers directly from H&E slides can also optimize diagnostic pathways. The open platform allows for customization and integration with existing lab systems, making the transition to AI-assisted pathology smoother.
Paige.AI's platform is designed for advanced integration capabilities, featuring open APIs that allow for unlimited vendor-neutral integrations with existing digital pathology applications, WSI scanners, and Laboratory Information Systems (LIS). This flexibility enables labs to customize workflows and seamlessly access both Paige's AI solutions and third-party AI applications within a single environment. They also partner with other AI pathology companies like Aiforia and Mindpeak to integrate their algorithms.
What the Web Says
Paige.AI is a company that has two main product offerings: an AI-powered platform for cancer diagnosis and biomarker discovery in pathology, and an AI-driven local SEO platform for Google Business Profile management. The healthcare-focused Paige.AI has received FDA approval for its AI-driven cancer diagnosis software, which assists pathologists in identifying regions of concern on digital slides, aiming to improve detection rates and reduce false negatives. The local SEO platform, often referred to as Paige by Merchynt, automates various aspects of Google Business Profile optimization, including post creation, review management, and image optimization, to enhance local search visibility.
Overall: PositiveStrengths
- Exceptional ease of use and intuitive features for the local SEO platform.
- Effective automation capabilities for Google Business Profile management and client reporting.
- Excellent customer support, with some users highlighting direct interaction with the CEO.
- Demonstrated improvement in Google Business Profile rankings and AI search visibility for local businesses.
- FDA approval for AI-driven cancer diagnosis in pathology, improving detection rates and reducing false negatives.
- Highly rated on Glassdoor for work/life balance, leadership, and overall employee satisfaction.
Limitations
- Editing limitations, such as inability to specify detailed requests for post rewrites, for the local SEO platform.
- Challenging learning curve for the local SEO platform, particularly with setup and understanding full capabilities.
- The local SEO product can be pricey, costing per client.
- Desire for more guided tutorials for the local SEO platform, especially for non-tech-savvy users.
- Narrow focus on prostate cancer limits the addressable market for the healthcare AI, with expansion to other cancer types being slow due to regulatory processes.
- Enterprise pricing and digital slide scanning infrastructure requirements can be barriers for smaller pathology labs for the healthcare AI.
Based on reviews from: G2, AI tool (aitool.info), Elion, Wellfound, Indeed.com, Software Advice, Automateed, Capterra, FeaturedCustomers, Paige.ai website, AHRQ (Agency for Healthcare Research and Quality), Reddit, YouTube
Last updated: 2026-07-21
Videos
News, demos, and interviews about Paige.AI.
Videos load interactively. If none appear, search YouTube for Paige.AI →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]